The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples